<i>Bacteroides uniformis</i> Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut-Liver Axis

Background: Type 2 diabetes mellitus (T2DM) is a metabolic syndrome characterized by chronic inflammation, insulin resistance, and islet cell damage. The prevention of T2DM and its associated complications is an urgent public health issue that affects hundreds of millions of people globally. Numerou...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue-Xue Zhu (Author), Chen-Yang Zhao (Author), Xin-Yu Meng (Author), Xiao-Yi Yu (Author), Lin-Chun Ma (Author), Tian-Xiao Chen (Author), Chang Chang (Author), Xin-Yu Chen (Author), Yuan Zhang (Author), Bao Hou (Author), Wei-Wei Cai (Author), Bin Du (Author), Zhi-Jun Han (Author), Li-Ying Qiu (Author), Hai-Jian Sun (Author)
Format: Book
Published: MDPI AG, 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e2d4fe55c5a84df289c8a067f0e23ca7
042 |a dc 
100 1 0 |a Xue-Xue Zhu  |e author 
700 1 0 |a Chen-Yang Zhao  |e author 
700 1 0 |a Xin-Yu Meng  |e author 
700 1 0 |a Xiao-Yi Yu  |e author 
700 1 0 |a Lin-Chun Ma  |e author 
700 1 0 |a Tian-Xiao Chen  |e author 
700 1 0 |a Chang Chang  |e author 
700 1 0 |a Xin-Yu Chen  |e author 
700 1 0 |a Yuan Zhang  |e author 
700 1 0 |a Bao Hou  |e author 
700 1 0 |a Wei-Wei Cai  |e author 
700 1 0 |a Bin Du  |e author 
700 1 0 |a Zhi-Jun Han  |e author 
700 1 0 |a Li-Ying Qiu  |e author 
700 1 0 |a Hai-Jian Sun  |e author 
245 0 0 |a <i>Bacteroides uniformis</i> Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut-Liver Axis 
260 |b MDPI AG,   |c 2024-08-01T00:00:00Z. 
500 |a 10.3390/ph17081015 
500 |a 1424-8247 
520 |a Background: Type 2 diabetes mellitus (T2DM) is a metabolic syndrome characterized by chronic inflammation, insulin resistance, and islet cell damage. The prevention of T2DM and its associated complications is an urgent public health issue that affects hundreds of millions of people globally. Numerous studies suggest that disturbances in gut metabolites are important driving forces for the pathogenesis of diabetes. However, the functions and mechanisms of action of most commensal bacteria in T2DM remain largely unknown. Methods: The quantification of bile acids (BAs) in fecal samples was performed using ultra-performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS). The anti-diabetic effects of <i>Bacteroides uniformis</i> (<i>B. uniformis</i>) and its metabolites cholic acid (CA) and chenodeoxycholic acid (CDCA) were assessed in T2DM mice induced by streptozocin (STZ) plus high-fat diet (HFD). Results: We found that the abundance of <i>B. uniformis</i> in the feces and the contents of CA and CDCA were significantly downregulated in T2DM mice. <i>B. uniformis</i> was diminished in diabetic individuals and this bacterium was sufficient to promote the production of BAs. Colonization of <i>B. uniformis</i> and intragastric gavage of CA and CDCA effectively improved the disorder of glucose and lipid metabolism in T2DM mice by inhibiting gluconeogenesis and lipolysis in the liver. CA and CDCA improved hepatic glucose and lipid metabolism by acting on the Takeda G protein-coupled receptor 5 (TGR5)/adenosine monophosphate-activated protein kinase (AMPK) signaling pathway since knockdown of TGR5 minimized the benefit of CA and CDCA. Furthermore, we screened a natural product-vaccarin (VAC)-that exhibited anti-diabetic effects by promoting the growth of <i>B. uniformis</i> in vitro and in vivo. Gut microbiota pre-depletion abolished the favorable effects of VAC in diabetic mice. Conclusions: These data suggest that supplementation of <i>B. uniformis</i> may be a promising avenue to ameliorate T2DM by linking the gut and liver. 
546 |a EN 
690 |a diabetes 
690 |a gut microbiome 
690 |a <i>Bacteroides uniformis</i> 
690 |a bile acid 
690 |a AMPK 
690 |a TGR5 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 17, Iss 8, p 1015 (2024) 
787 0 |n https://www.mdpi.com/1424-8247/17/8/1015 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/e2d4fe55c5a84df289c8a067f0e23ca7  |z Connect to this object online.